DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20194267

Evaluation of safety and efficacy of intravenous iron sucrose therapy for moderate anaemia in antenatal women

K. P. Poojitha, B. S. B. Mallika, K. V. Siva Prasad

Abstract


Background: Prevalence of iron deficiency anaemia is high in developing countries like India. Treatment of iron deficiency anaemia in pregnancy is very important to bring down maternal mortality rate as blood loss during delivery can lead to death of the patient. The aim and objective of our study is to evaluate the efficacy and safety of intravenous iron sucrose infusions in antenatal women admitted in hospital suffering from moderate iron deficiency anaemia. Special emphasis was given to observe adverse drug effects.

Methods: This was a prospective observational study conducted in Obstetrics and Gynaecology department, Government General Hospital, Rangaraya Medical College, Kakinada, Andhra Pradesh. Study period was two months and study population included antenatal women with gestational age less than 37 weeks with moderate iron deficiency anaemia. Peripheral smear was examined for microcytic hypochromic anaemia and they were treated with intravenous infusion of iron sucrose. Haemoglobin levels were checked before and 5 weeks after iron infusions. Monitoring was done for adverse reactions.

Results: Out of 322 admissions, 95% were found to be anaemic. 72 patients were suffering from moderate anaemia from which 25 have been included and treated with intravenous iron sucrose infusions. They were observed for efficacy and safety parameters. Two minor adverse events were reported (fever with chills and angioedema of lips) and they were excluded from study. Mean haemoglobin concentration was found to be raised from 7.08±0.73 (SD) to 11.33±0.48 (SD) within 5 weeks for 23 patients.

Conclusions: Iron sucrose infusion is safe and effective for anaemia in pregnancy.


Keywords


Pregnant women, Iron deficiency anaemia, Iron sucrose infusions

Full Text:

PDF

References


Kimble K, Anne M. Koda-Kimble and Young’s applied therapeutics: the clinical use of drugs. In: Alldredge BK, Corelli RL, Ernst ME. 10th ed. Wolters Kluwer: Lippincott Williams and Wilkins; 2012.

National Family Health Survey-3. Ministry of Health and Family Welfare, Government of India.

Gragnolati M, Shekar M, Gupta DM, Bredenkamp C, Lee YK. India’s undernourished children: a call for reform and action. Washington, DC: Health, Nutrition and Population; 2005.

Toteja GS, Singh P, Dhillon BS, Saxena BN, Ahmed FU, Singh RP, et al. Prevalence of anaemia among pregnant women and adolescent girls in 16 districts of India. Food Nutr Bull. 2006;27:311-5.

Kriplani A, Mahey R, Dash BB, Kulshreshta V, Agarwal N, Bhatla N. Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. Indian J Med Res. 2013;138(1):78.

District Level Household and Facility Survey-4 (DLHS-4). Ministry of Health and Family Welfare, Government of India, 2012-13.

Dutta DC. Anaemia in pregnancy. Text book of obstetrics including perinatology and contraception. 6th ed. Calcutta: New Central Book Agency (P) Ltd.; 2004: 262-267.

Goodman and Gilman’s the pharmacological basis of therapeutics. In: Brunton LL, Dandan RH, Knollmann BC, eds. 13th ed. New York: McGraw-Hill Medical; 2011.

Williams obstetrics. In: Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, et al, eds. 25th ed. McGraw-Hill/Appleton and Lange; 1989.

Panchal PJ, Desai MK, Shah SP, Solanki MN. Evaluation of efficacy, safety and cost of oral and parenteral iron preparations in patients with iron deficiency anemia. J Appl Pharm Sci. 2015;5(03):066-72.

Morales-Borges R. Anemia in pregnancy and parenteral iron therapy. J Blood Disord Trans. 2013;4(171):2.